WHO Pharmaceuticals Newsletter 2003, No. 03
(2003; 14 pages) Voir le document au format PDF
Table des matières
Fermer ce répertoireREGULATORY MATTERS
Afficher le documentACETYLSALICYLIC ACID - MHRA confirms labelling change
Afficher le documentACITRETIN - Warnings of depression added to label
Afficher le documentASTEMIZOLE - Withdrawn due to life-threatening ventricular arrhythmias
Afficher le documentCAMELIA SINENSIS - Ethanolic extract products withdrawn due to hepatotoxicity
Afficher le documentDIETARY SUPPLEMENTS - Withdrawal of two products due to presence of sildenafil
Afficher le documentHUA FO - Presence of tadalafil
Afficher le documentIODINE - Some products contain more than the RDA
Afficher le documentLEVODOPA/CARBIDOPA - New warning about somnolence and sudden onset sleep
Afficher le documentLINDANE - Additional warnings and medication guide added to label
Afficher le documentNEFAZODONE - Regulatory status update
Afficher le documentNIMESULIDE - Paediatric preparations banned in Bangladesh
Afficher le documentPERGOLIDE MESYLATE - Risk of cardiac valvulopathy
Afficher le documentREPAGLINIDE - Contraindicated with gemfibrozil
Afficher le documentRISPERIDONE - Prescribing information updated to reflect cardiovascular adverse events
Afficher le documentTELITHROMYCIN - Aggravation of myasthenia gravis
Ouvrir ce répertoire et afficher son contenuSAFETY OF MEDICINES
Ouvrir ce répertoire et afficher son contenuCURRENT CONCERNS
Ouvrir ce répertoire et afficher son contenuDRUGS OF INTEREST
Ouvrir ce répertoire et afficher son contenuFEATURE
 

DIETARY SUPPLEMENTS - Withdrawal of two products due to presence of sildenafil

USA. Two dietary supplement products (Vinarol from Ultra Health Laboratories Inc and Bionate Inc and Viga from Best Life International) are being voluntarily recalled by the respective companies due to the unlabeled presence of sildenafil, a prescription drug that could have serious health risks if used without medical supervision. Both products were being sold as dietary supplements, without a prescription, for increasing desire, confidence and sexual performance. Consumers who have purchased either of these products are urged to discontinue their use.

Reference:

1. Medwatch Safety Alert, 4 Apr 2003. Available from URL: http://www.fda.gov/medwatch/SAFETY/2003/vinarol.htm

2. Medwatch Safety Alert, 23 May 2003. Available from URL: http://www.fda.gov/medwatch/SAFETY/2003/vinarol.htm

vers la section précédente
vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019